ABOUT ADICET BIO
Adicet Bio, Inc. is developing novel universal immune cell therapies based on gamma delta T cells engineered with Chimeric Antigen Receptors. Adicet is also focused on identifying and validating cancer specific targets directed to the intracellular proteome and then generating T Cell Receptor-like monoclonal antibodies MAbs (TCRLs) directed to these cancer-specific peptide targets presented by MHC Class I complexes. These TCRLs are being used to arm T cells or as T cell engagers in solid tumors. In August 2016, Adicet entered into a strategic collaboration with Regeneron Pharmaceuticals, Inc. to develop next-generation engineered immune-cell therapeutics using Adicet's gamma delta T cell allogeneic platform technology. Adicet Bio was recognized and named by FierceBiotech as a “Fierce 15” Biotech Company in 2016.
For more information, please visit our website at http://www.adicetbio.com.
PROCESS DEVELOPMENT ENGINEER II
The Process Development team is building the next generation manufacturing process to advance the platform of “off-the-shelf” Immune Cell Products. Applying the latest cell therapy technologies and bioprocess practices, we are a team of experienced and motivated scientists and engineers focusing on delivery results through collaboration and innovation.
We are seeking a highly motivated and experienced individual with a strong background in cell process development. Specifically, this individual will be tasked to support development and optimization of manufacturing processing steps from the harvest up to the cryopreservation of the immune cell product. The successful candidate will execute laboratory studies to support process design and development, process characterization, and continuous process improvements. You will also support and contribute to regulatory submissions and technology transfers.
Launch your career - Create your profile now!Create your Profile
Loading some great jobs for you...